Literature DB >> 14764900

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.

Stefan F Wieland1, Hans Christian Spangenberg, Robert Thimme, Robert H Purcell, Francis V Chisari.   

Abstract

We have previously shown that hepatitis B virus (HBV) replication is controlled by noncytolytic mechanisms that depend primarily on the effector functions of the CD8(+) T cell response, especially the production of IFN-gamma in the liver. The mechanisms that control the nuclear pool of viral covalently closed circular DNA (cccDNA) transcriptional template of HBV, which must be eliminated to eradicate infection, have been difficult to resolve. To examine those mechanisms, we quantitated intrahepatic HBV cccDNA levels in acutely infected chimpanzees whose virological, immunological, and pathological features were previously described. Our results demonstrate that the elimination kinetics of the cccDNA are more rapid than the elimination of HBV antigen-positive hepatocytes during the early phase of viral clearance, and they coincide with the influx of small numbers of IFN-gamma producing CD8(+) T cells into the liver. In contrast, terminal clearance of the cccDNA is associated with the peak of liver disease and hepatocellular turnover and with a surge of IFN-gamma producing CD8(+) T cells in the liver. Collectively, these results suggest that cccDNA clearance is a two-step process mediated by the cellular immune response. The first step reduces the pool of cccDNA molecules noncytolytically, probably by eliminating their relaxed circular DNA precursors and perhaps by destabilizing them. The second step enhances this process by destroying infected hepatocytes and triggering their turnover. Surprisingly, despite this multipronged response, traces of cccDNA persist indefinitely in the liver, likely providing a continuous antigenic stimulus that confers lifelong immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764900      PMCID: PMC357063          DOI: 10.1073/pnas.0308478100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Low dynamic state of viral competition in a chronic avian hepadnavirus infection.

Authors:  Y Y Zhang; J Summers
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections.

Authors:  J T Guo; H Zhou; C Liu; C Aldrich; J Saputelli; T Whitaker; M I Barrasa; W S Mason; C Seeger
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Authors:  H McClary; R Koch; F V Chisari; L G Guidotti
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

Authors:  Y Zhu; T Yamamoto; J Cullen; J Saputelli; C E Aldrich; D S Miller; S Litwin; P A Furman; A R Jilbert; W S Mason
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.

Authors:  S F Wieland; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells.

Authors:  Qing Zhu; Ju-Tao Guo; Christoph Seeger
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Hepatocyte turnover during resolution of a transient hepadnaviral infection.

Authors:  Jesse Summers; Allison R Jilbert; Wengang Yang; Carol E Aldrich; Jeffry Saputelli; Samuel Litwin; Eugene Toll; William S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

10.  Conditional replication of duck hepatitis B virus in hepatoma cells.

Authors:  Ju-Tao Guo; Melissa Pryce; Xingtai Wang; M Inmaculada Barrasa; Jianming Hu; Christoph Seeger
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  89 in total

1.  Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration.

Authors:  Colin A Bill; Jesse Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

2.  Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR.

Authors:  Jun Liu; Ying-Hui Li; Jin Ding; Wei-Dong Gong; Cai-Fang Xue; Ya Zhao; Yu-Xiao Huang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

4.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 5.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

6.  The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.

Authors:  William S Mason; Chunxiao Xu; Huey Chi Low; Jeffry Saputelli; Carol E Aldrich; Catherine Scougall; Arend Grosse; Richard Colonno; Sam Litwin; Allison R Jilbert
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

Authors:  Michael D Robek; Mayra L Garcia; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.